- Home
- BRY vs SOPH Comparison
BRY vs SOPH Comparison
Compare BRY & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRY
- SOPH
- Stock Information
- Founded
- BRY 1909
- SOPH 2011
- Country
- BRY United States
- SOPH Switzerland
- Employees
- BRY N/A
- SOPH N/A
- Industry
- BRY Oil & Gas Production
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BRY Energy
- SOPH Health Care
- Exchange
- BRY Nasdaq
- SOPH Nasdaq
- Market Cap
- BRY 249.1M
- SOPH 231.8M
- IPO Year
- BRY N/A
- SOPH 2021
- Fundamental
- Price
- BRY $3.37
- SOPH $5.00
- Analyst Decision
- BRY Hold
- SOPH
- Analyst Count
- BRY 2
- SOPH 0
- Target Price
- BRY $4.00
- SOPH N/A
- AVG Volume (30 Days)
- BRY 759.4K
- SOPH 143.5K
- Earning Date
- BRY 11-05-2025
- SOPH 11-04-2025
- Dividend Yield
- BRY 3.56%
- SOPH N/A
- EPS Growth
- BRY N/A
- SOPH N/A
- EPS
- BRY 0.07
- SOPH N/A
- Revenue
- BRY $701,914,000.00
- SOPH $69,688,000.00
- Revenue This Year
- BRY N/A
- SOPH $16.60
- Revenue Next Year
- BRY N/A
- SOPH $19.09
- P/E Ratio
- BRY $51.72
- SOPH N/A
- Revenue Growth
- BRY N/A
- SOPH 7.32
- 52 Week Low
- BRY $2.11
- SOPH $2.58
- 52 Week High
- BRY $5.90
- SOPH $5.30
- Technical
- Relative Strength Index (RSI)
- BRY 42.77
- SOPH 63.97
- Support Level
- BRY $3.28
- SOPH $4.01
- Resistance Level
- BRY $3.41
- SOPH $4.36
- Average True Range (ATR)
- BRY 0.10
- SOPH 0.39
- MACD
- BRY -0.01
- SOPH 0.05
- Stochastic Oscillator
- BRY 36.62
- SOPH 80.65
About BRY Berry Corporation (bry)
Berry Corp (bry) is a western United States independent upstream energy company with a focus on the conventional, long-lived oil reserves in the San Joaquin basin of California. Its operating segments includes Exploration and Production (E&P) and Well Servicing and Abandonment. The company generates maximum revenue from the Exploration and Production (E&P) segment.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.